{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:20:52Z","timestamp":1771928452044,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The immunological drivers of portal hypertension regression after hepatitis C virus (HCV) cure are poorly understood, particularly in the context of human immunodeficiency virus (HIV) coinfection We aimed to identify baseline immune signatures predicting the evolution of the hepatic venous pressure gradient (HVPG) in people with and without HIV (PWH\/PWoH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We prospectively followed 41 individuals with advanced cirrhosis (18 PWoH, 23 PWH) who were cured of HCV with direct-acting antivirals (DAA). Baseline plasma and cellular immune markers were extensively profiled using multiplex assays and flow cytometry. We used mixed-effects modeling to test for associations between these baseline immune features and the change in HVPG over a 48-week follow-up period, with q-values controlling for false discoveries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two distinct immunological profiles of impaired HVPG regression emerged. In PWoH, impaired regression was linked to a broad proinflammatory profile [TNF-\u03b1 (AMR = 1.13; q=0.012), IL17A (AMR = 1.28; q=0.012), and IL10 (AMR = 1.2; q=0.028)], a widespread total CD4+ T-cell activation [HLA-DR+ (AMR = 1.44; q&amp;lt;0.001) and CD38+HLA-DR+ (AMR = 1.3; q=0.007)], and robust activation across central memory (CM) and effector memory (EM) subsets. Conversely, in PWH, impaired HVPG regression was associated with sVCAM-1 (AMR = 1.58; q=0.096), and a more focused activation within EM (HLA-DR+, AMR = 1.08; q=0.030) and TemRA (CD38+HLA-DR+, AMR = 1.12; q=0.030) CD4+ T-cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>HIV coinfection fundamentally reshapes the immunological landscape of post-cure portal hypertension recovery. The shift from systemic inflammation in PWoH to endothelial dysfunction and T-cell exhaustion in PWH reveals distinct pathological pathways. Understanding these signatures is a crucial step toward developing targeted therapies to promote complete hepatic recovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1683092","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:32:35Z","timestamp":1770013955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["HIV status defines distinct immunological drivers of persistent portal hypertension after HCV cure in people with advanced cirrhosis"],"prefix":"10.3389","volume":"17","author":[{"given":"Rub\u00e9n","family":"Mart\u00edn-Escolano","sequence":"first","affiliation":[{"name":"Unidad de Infecci\u00f3n Viral e Inmunidad, Centro Nacional de Microbiolog\u00eda (CNM), Instituto de Salud Carlos III (ISCIII)","place":["Majadahonda, Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Fern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Unidad de Infecci\u00f3n Viral e Inmunidad, Centro Nacional de Microbiolog\u00eda (CNM), Instituto de Salud Carlos III (ISCIII)","place":["Majadahonda, Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Tarancon-Diez","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Grupo de Infecciones en la Poblaci\u00f3n Pedi\u00e1trica, Instituto de Investigaci\u00f3n Sanitaria del Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Berenguer","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Unidad de Enfermedades Infecciosas\/VIH; Hospital General Universitario \u201cGregorio Mara\u00f1\u00f3n\u201d","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria del Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Codina","sequence":"additional","affiliation":[{"name":"Unidad de Infecci\u00f3n Viral e Inmunidad, Centro Nacional de Microbiolog\u00eda (CNM), Instituto de Salud Carlos III (ISCIII)","place":["Majadahonda, Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Amigot-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Unidad de Infecci\u00f3n Viral e Inmunidad, Centro Nacional de Microbiolog\u00eda (CNM), Instituto de Salud Carlos III (ISCIII)","place":["Majadahonda, Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Unidad de VIH, Servicio de Medicina Interna, Hospital Universitario \u201cLa Paz\u201d","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Honta\u00f1\u00f3n","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Unidad de VIH, Servicio de Medicina Interna, Hospital Universitario \u201cLa Paz\u201d","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leire","family":"P\u00e9rez-Latorre","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Unidad de Enfermedades Infecciosas\/VIH; Hospital General Universitario \u201cGregorio Mara\u00f1\u00f3n\u201d","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Iba\u00f1ez-Samaniego","sequence":"additional","affiliation":[{"name":"Servicio de Aparato Digestivo, Hospital General Universitario \u201cGregorio Mara\u00f1\u00f3n\u201d","place":["Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Hep\u00e1ticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elba","family":"Llop-Herrera","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Hep\u00e1ticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Departamento de Gastroenterolog\u00eda, Hospital Universitario Puerta de Hierro-Majadahonda","place":["Majadahonda, Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Olveira","sequence":"additional","affiliation":[{"name":"Servicio de Aparato Digestivo, Hospital Universitario La Paz","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"D\u00edaz","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria del Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Unidad de Citometr\u00eda de Flujo y Sorter, Hospital General Universitario \u201cGregorio Mara\u00f1\u00f3n\u201d","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidoro","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Unidad de Infecci\u00f3n Viral e Inmunidad, Centro Nacional de Microbiolog\u00eda (CNM), Instituto de Salud Carlos III (ISCIII)","place":["Majadahonda, Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Jim\u00e9nez-Sousa","sequence":"additional","affiliation":[{"name":"Unidad de Infecci\u00f3n Viral e Inmunidad, Centro Nacional de Microbiolog\u00eda (CNM), Instituto de Salud Carlos III (ISCIII)","place":["Majadahonda, Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[{"name":"Unidad de Infecci\u00f3n Viral e Inmunidad, Centro Nacional de Microbiolog\u00eda (CNM), Instituto de Salud Carlos III (ISCIII)","place":["Majadahonda, Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1177\/2050640619840149","article-title":"Hepatitis C virus therapy in advanced liver disease: Outcomes and challenges","volume":"7","author":"Ekpanyapong","year":"2019","journal-title":"United Eur Gastroenterol J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00535-022-01940-1","article-title":"Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR","volume":"58","author":"Nakagawa","year":"2023","journal-title":"J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.007","article-title":"EASL position paper on clinical follow-up after HCV cure","volume":"81","author":"Reiberger","year":"2024","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cld.2024.03.009","article-title":"Hepatic venous pressure gradient: measurement and pitfalls","volume":"28","author":"Rodrigues","year":"2024","journal-title":"Clin Liver Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.08.006","article-title":"Hepatic benefits of HCV cure","volume":"73","author":"Calvaruso","year":"2020","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.726419","article-title":"A tale of two viruses: immunological insights into HCV\/HIV coinfection","volume":"12","author":"Gobran","year":"2021","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gines","year":"2021","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.723196","article-title":"HCV cure with direct-acting antivirals improves liver and immunological markers in HIV\/HCV-coinfected patients","volume":"12","author":"BroChado-Kith","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/v12080799","article-title":"Reversal of T cell exhaustion in chronic HCV infection","volume":"12","author":"Osuch","year":"2020","journal-title":"Viruses"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7316456","DOI":"10.1155\/2021\/7316456","article-title":"HIV-related immune activation and inflammation: current understanding and strategies","volume":"2021","author":"Lv","year":"2021","journal-title":"J Immunol Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e00773-20","DOI":"10.1128\/AAC.00773-20","article-title":"Modulation of monocyte activation and function during direct antiviral agent treatment in patients coinfected with HIV and hepatitis C virus","volume":"64","author":"De Pablo-Bernal","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"B14","doi-asserted-by":"publisher","first-page":"114587","DOI":"10.1016\/j.biopha.2023.114587","article-title":"Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV\/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy","volume":"162","author":"Tarancon-Diez","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2012.711848","article-title":"Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis","volume":"48","author":"Rincon","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001787","article-title":"Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV\/hepatitis C virus-coinfected patients","volume":"32","author":"Medrano","year":"2018","journal-title":"AIDS"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"26996","DOI":"10.1038\/srep26996","article-title":"The statistical value of raw fluorescence signal in luminex xMAP based multiplex immunoassays","volume":"6","author":"Breen","year":"2016","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.10.030","article-title":"Bead-based multiplex immuno-assays for cytokines, chemokines, growth factors and other analytes: median fluorescence intensities versus their derived absolute concentration values for statistical analysis","volume":"71","author":"Breen","year":"2015","journal-title":"Cytokine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"114913","DOI":"10.1016\/j.biopha.2023.114913","article-title":"Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV\/HCV-coinfected patients","volume":"164","author":"Martin-Escolano","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01926","article-title":"Direct-acting antiviral treatment of HCV infection does not resolve the dysfunction of circulating CD8(+) T-cells in advanced liver disease","volume":"10","author":"Vranjkovic","year":"2019","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.019","article-title":"Increased peripheral CD4(+) regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C","volume":"66","author":"Langhans","year":"2017","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.3390\/ijms23179773","article-title":"IL-17A in human liver: significant source of inflammation and trigger of liver fibrosis initiation","volume":"23","author":"Kartasheva-Ebertz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1497095","article-title":"The role of the interleukin family in liver fibrosis","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148537","article-title":"Soluble adhesion molecules in patients coinfected with HIV and HCV: A predictor of outcome","volume":"11","author":"Aldamiz-Echevarria","year":"2016","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833ce54d","article-title":"Hepatitis C virus infection is associated with endothelial dysfunction in HIV\/hepatitis C virus coinfected patients","volume":"24","author":"de Castro","year":"2010","journal-title":"AIDS"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2014.12.033","article-title":"T cell exhaustion during persistent viral infections","author":"Kahan","year":"2015","journal-title":"Virology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1101\/2025.02.17.25321289","article-title":"Alterations in the hepatic microenvironment following direct-acting antiviral therapy for chronic hepatitis C","volume":"18","author":"Millian","year":"2025","journal-title":"medRxiv"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.3390\/v13102074","article-title":"CCR5+ T-cells homed to the liver exhibit inflammatory and profibrogenic signatures in chronic HIV\/HCV-coinfected patients","volume":"13","author":"Shrivastava","year":"2021","journal-title":"Viruses"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1683092\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:29:38Z","timestamp":1771925378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1683092\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2026.1683092"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1683092","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"article-number":"1683092"}}